Women In Nutraceuticals, a non-profit spearheaded by a cohort of global nutraceutical leaders, has commissioned research to benchmark data on women’s roles in the industry.
At this year’s SupplySide West, Women In Nutraceuticals (Chandler, AZ; WIN), a non-profit spearheaded by a cohort of global nutraceutical leaders, said it has commissioned research to benchmark data on women’s roles in the industry. The research will be conducted by NEXT, a division of Informa, and will include the United States, Europe, and Asia. Outreach will be conducted in the last months of 2022, and the report presented in early spring of 2023.
“There is a perception that top leadership across the nutraceutical community is primarily male; however, we can’t rely on gut feelings when seeking to make change—we need data,” WIN president Heather Granato said in a press release. “This benchmarking study will offer a point-in-time assessment of gender representation in the C-suite and top leadership. In turn, the broader industry and the companies within it can make informed decisions and set a path that will move the needle toward a more inclusive and representative industry.”
Informa is financially supporting the research project, in addition to its Platinum sponsorship of WIN. “I’m proud to join the leaders of brand families across Informa Markets—Food ingredients, New Hope Network, SupplySide, and Vitafoods—in supporting WIN’s project to assess gender representation,” said Danica Cullins, senior vice president of SupplySide, said in a press release. “Having the benchmark study data will not only serve as an important foundation for focused work, it will also allow future measures of improvement. We look forward to collaborating with WIN along each step of this journey to better serve the nutraceuticals community and its stakeholders.”
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.